Pharmaceutical companies in the United States by P/B ratio

Share price divided by book value per share: what the market pays for each dollar of shareholders' equity on the balance sheet.

Viatris has the lowest figure of the 39 pharmaceutical companies in the United States ranked by P/B ratio, at 1.7, followed by Pfizer (1.8) and BioMarin Pharmaceutical (1.9). Figures as of 19 Nov 2026, 22:07 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
39
Lowest
Viatris1.7
Median
6.9
Combined market value
$3.74T
Countries
1
Not ranked
5no P/B ratio on file

Market values as of .

United States
All sectors
Pharmaceuticals
USD
Clear filters
Pharmaceutical companies in the United States by P/B ratio
#CompanyP/B ↑Market capPriceToday1 yearPrice, 30 daysCountry
1ViatrisVTRS · Health Care1.7$22.8B$19.88 1.97% down 99% up United States
2PfizerPFE · Health Care1.8$157B$27.54 1.85% down 15% up United States
3BioMarin PharmaceuticalBMRN · Health Care1.9$11.9B$61.42 0.02% down 17% up United States
4Elanco Animal HealthELAN · Health Care2.0$13.1B$26.29 1.54% down 26% up United States
5Legend BiotechLEGN · Health Care2.5$3.1B$16.10 0.92% down 41% down United States
6Edgewise TherapeuticsEWTX · Health Care2.8$4.5B$41.17 0.48% down 86% up United States
7Regeneron PharmaceuticalsREGN · Health Care2.8$95.5B$923.34 2.35% down 28% up United States
8Abbott LaboratoriesABT · Health Care3.5$179.9B$103.87 0.58% down 16% down United States
9United TherapeuticsUTHR · Health Care3.8$23.8B$559.10 3.16% down 22% up United States
10Dianthus TherapeuticsDNTH · Health Care3.8$4.8B$84.83 1.01% up 108% up United States
11Definium TherapeuticsDFTX · Health Care4.2$4B$29.48 1.24% up 168% up United States
12Royalty PharmaRPRX · Health Care4.4$38.9B$67.72 1.38% down 79% up United States
13Bristol-Myers SquibbBMY · Health Care5.1$119.3B$58.34 2.05% down 30% up United States
14ErascaERAS · Health Care5.4$5B$14.22 3.34% up 395% up United States
15Oruka TherapeuticsORKA · Health Care5.5$6.6B$97.57 1.91% up 255% up United States
16Alnylam PharmaceuticalsALNY · Health Care5.5$19.8B$147.82 1.06% down 66% down United States
17Ligand PharmaceuticalsLGND · Health Care6.0$5.7B$286.94 3.94% down 50% up United States
18Vertex PharmaceuticalsVRTX · Health Care6.3$132B$520.66 2.94% down 27% up United States
19VeradermicsMANE · Health Care6.6$5.2B$124.39 0.38% down 231% up United States
20Praxis Precision MedicinesPRAX · Health Care6.9$8.7B$310.90 1.87% up 86% up United States
21Merck & CoMRK · Health Care7.3$327.4B$132.81 3.61% down 45% up United States
22Protagonist TherapeuticsPTGX · Health Care7.5$8.1B$124.02 2.47% down 51% up United States
23Belite BioBLTE · Health Care7.7$6.1B$151.02 3.33% down 43% up United States
24Johnson & JohnsonJNJ · Health Care7.9$643.1B$267.14 2.04% down 34% up United States
25Corcept TherapeuticsCORT · Health Care8.5$7.1B$64.98 4.15% down 10% down United States
26Spyre TherapeuticsSYRE · Health Care9.7$9.3B$97.63 3.77% down 332% up United States
27ZoetisZTS · Health Care10.0$32.8B$80.79 5.59% down 26% down United States
28Cogent BiosciencesCOGT · Health Care10.7$4.8B$27.74 0.25% down 20% down United States
29Ionis PharmaceuticalsIONS · Health Care11.5$4.5B$27.22 0.62% down 63% down United States
30Amneal PharmaceuticalsAMRX · Health Care14.0$7.5B$21.39 2.24% down 90% up United States
31Madrigal PharmaceuticalsMDGL · Health Care14.7$9.2B$396.74 0.34% down 27% down United States
32Summit TherapeuticsSMMT · Health Care15.0$8.5B$10.57 0.67% up 36% down United States
33TG TherapeuticsTGTX · Health Care15.9$9.8B$64.88 1.88% down 117% up United States
34Eli LillyLLY · Health Care29.9$1.20T$1,351.12 2.29% down 33% up United States
35InsmedINSM · Health Care43.6$31.7B$144.46 20.58% up 40% down United States
36Axsome TherapeuticsAXSM · Health Care67.7$7.1B$135.68 1.25% up 6% down United States
37Rhythm PharmaceuticalsRYTM · Health Care92.0$8.1B$116.80 1.88% down 18% up United States
38Arrowhead PharmaceuticalsARWR · Health Care123$6.2B$43.65 1.25% up 13% up United States
39Travere TherapeuticsTVTX · Health Care205$4.6B$48.30 3.86% down 45% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. 5 companies have no P/B ratio on file and are not ranked here.

Questions and answers

Which pharmaceutical companies in the United States have the lowest P/B ratio?

Viatris (1.7), Pfizer (1.8) and BioMarin Pharmaceutical (1.9) have the lowest P/B ratio of the 39 pharmaceutical companies in the United States ranked here as of 19 Nov 2026, 22:07 UTC.

How many pharmaceutical companies in the United States are in this ranking?

39 are ranked by P/B ratio. 5 more have no P/B ratio on file and are left out rather than ranked at zero.

What are these pharmaceutical companies in the United States worth together?

The 39 pharmaceutical companies in the United States ranked by P/B ratio have a combined market value of $3.74T as of 19 Nov 2026, 22:07 UTC.

What does ranking by P/B ratio measure?

Share price divided by book value per share: what the market pays for each dollar of shareholders' equity on the balance sheet.

Cite this page

Funkfolio, “Pharmaceutical companies in the United States by P/B ratio”, data as of 19 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?country=united-states&by=pb-ratio

Underlying data: Yahoo Finance; SEC EDGAR.